Most women with hormone-driven hair loss have a normal testosterone result. In the guides we publish here, this is the gap that sends readers to a hormone panel expecting an answer it cannot give. The conversion of testosterone into DHT happens inside the follicle, and no blood test measures that step or the receptor that responds to it.
Testing still earns its place. It finds the thyroid disease, the iron depletion, and the androgen excess that either mimic the pattern or make it worse.
The Verdict
The Fork That Comes First
Before any hormone gets discussed, one distinction decides everything downstream. Hair can thin because each follicle is shrinking, or it can shed because many follicles entered the resting phase at once.
| Female pattern hair loss | Telogen effluvium | |
|---|---|---|
| What you notice | The part line widens. Hair volume drops at the crown while the front hairline holds | Handfuls come out in the shower or the brush, all over the head at once |
| How fast | Gradual, over years, often noticed in photographs rather than in the moment | Sudden, and usually two to three months after the event that caused it |
| What is happening to the follicle | It shrinks. Each cycle produces a finer, shorter hair until it stops producing one | It is alive and has been pushed into the resting phase early, all at the same time |
| What happens next | Progressive without treatment | Recovers on its own once the trigger has passed, usually over six to nine months |
| What blood tests are for | Ruling out the conditions that mimic or worsen it, not confirming it | Finding the trigger, which is often thyroid, iron, or a recent illness |
The timing clue is the most useful thing on that table. Because resting hairs sit in place for two to three months before releasing, the shed always lags its cause. People reliably blame the wrong month. A shed that started in March points at a January event, and January is usually when the illness, the surgery, the crash diet, or the loss actually happened.
The two also coexist. A woman with early pattern loss who then has a baby or a bad flu gets both at once, which is why the shed feels catastrophic and the recovery feels incomplete.
Which Hormones Are Doing What
| Hormone | How it acts on the follicle | What it means in practice |
|---|---|---|
| DHT (dihydrotestosterone) | Converted from testosterone by 5-alpha-reductase inside the follicle. Binds the androgen receptor and shortens the growth phase | The central mechanism in female pattern hair loss, and it operates at the follicle even when blood androgens read normal |
| Estrogen | Extends the growth phase. When it falls, the growth phase shortens | Explains the postpartum shed and why thinning often starts or accelerates through perimenopause |
| Thyroid hormones | Set the metabolic rate of the follicle. Too little or too much disrupts the cycle | Both an underactive and an overactive thyroid cause diffuse shedding. TSH is the screening test |
| Cortisol | Sustained elevation pushes follicles into the resting phase together | The mechanism behind stress-related shedding, and the reason the timing lags the stressor |
| Insulin | High insulin raises free androgens by suppressing SHBG, the protein that binds them | The link between insulin resistance, PCOS, and androgen-driven thinning |
| Progesterone | Falls earlier than estrogen in perimenopause, shifting the balance toward androgens | Contributes to the pattern rather than causing it alone |
DHT is the one worth understanding properly. Testosterone circulates and is converted locally by 5-alpha-reductase inside susceptible follicles, and the DHT produced there binds androgen receptors and shortens the growth phase. Each cycle the follicle produces a slightly finer, slightly shorter hair. Eventually it produces one you cannot see.
Susceptibility is inherited and local, which explains the pattern. The follicles at the crown carry the sensitivity. The ones at the back of the head largely do not, which is the same reason hair transplants work at all.
The insulin link is the one readers usually have not heard. Insulin suppresses SHBG, the liver protein that binds testosterone and keeps it inactive. Lower SHBG means a higher free fraction available for conversion into DHT, with no change in total testosterone. This is one of the routes through which insulin resistance shows up in the hair, and our page on PCOS and insulin resistance covers the wider picture.
What a Panel Can and Cannot Tell You
| Test | What it finds | The caveat |
|---|---|---|
| TSH, with free T4 if abnormal | Thyroid disease, in either direction | One of the few results that reliably changes management |
| Ferritin | Iron stores, which sit low far more often than a normal haemoglobin suggests | No consensus threshold exists for hair. Dermatologists commonly act below 30 ng/mL, and the evidence behind that number is weak |
| Full blood count | Anaemia, and a baseline for iron work | Haemoglobin can be normal while ferritin is depleted |
| Total and free testosterone with SHBG | Androgen excess, which points toward PCOS or another cause | Normal results do not rule out androgen-driven thinning. Follicle sensitivity is not measured by a blood test |
| DHEA-S | An adrenal source of androgens | A markedly raised result changes the investigation rather than the hair treatment |
| Vitamin D | Deficiency, which is associated with several hair disorders | The association is consistent. Whether correcting it regrows hair is not established |
Read that table for what is absent. Nothing on it confirms female pattern hair loss, because the diagnosis is made by looking at the scalp and the pattern rather than by measuring blood. The American Academy of Dermatology describes the examination, including magnified inspection of the part line for variation in hair shaft calibre, as the basis for that call.
Ferritin deserves a note because it is the marker most often misread. Iron stores can be empty while haemoglobin sits comfortably in range, so a normal full blood count is not reassurance. The number circulating online as a target for hair growth has no agreed evidence behind it, and taking iron that is not needed is not harmless. If you want the marker explained in full, our ferritin guide covers what the ranges mean.
What the Evidence Says About Treatment
Topical minoxidil is the only medicine approved by the FDA for hair loss in women, sold as a 2% solution and a 5% foam. It extends the growth phase and works while it is being used, with shedding resuming if it stops. It does not address androgens at all.
Finasteride and dutasteride block 5-alpha-reductase and therefore act on the mechanism directly. Neither is approved for women, and both are contraindicated in anyone who could become pregnant because of the risk to the development of a male fetus. Spironolactone blocks the androgen receptor and is prescribed off-label for this purpose in some countries. Low-level laser devices hold FDA clearance rather than approval, a lower bar that establishes similarity to an existing device rather than proof of effect.
Supplements marketed for hair are a weaker story than the packaging suggests. Correcting a documented deficiency in iron, vitamin D, or zinc is reasonable. Taking them without a deficiency has not been shown to grow hair. Biotin is worse than useless here: at supplement doses it interferes with several common laboratory assays, including thyroid and troponin tests. That means it can distort the very panel being run to investigate the hair loss. Laboratories publish how long to stop it before a draw, so tell whoever orders the test that you take it.
Who This Does Not Cover
Patchy, coin-shaped bald spots with smooth skin are not hormonal. That pattern points toward alopecia areata, an autoimmune condition with a different workup and different treatments. Scarring at the hairline, redness, itching, burning, or visible loss of follicle openings suggests a scarring alopecia such as frontal fibrosing alopecia, where delay costs permanent follicles. Both need a dermatologist rather than a hormone panel.
What would change our reading: a validated test for follicle androgen sensitivity. Receptor density and local 5-alpha-reductase activity determine who gets pattern hair loss, and neither is measurable outside a biopsy today. If a blood or scalp test made that visible, the hormone panel would stop being a process of elimination and start answering the question women arrive with.
Frequently Asked Questions
Which hormone causes hair loss in women?
Dihydrotestosterone, usually written as DHT, is the one acting directly on the follicle. An enzyme called 5-alpha-reductase makes it from testosterone inside the hair follicle itself. It then binds androgen receptors there and shortens each growth cycle, until the follicle produces only a fine, short hair. Falling estrogen, thyroid disease, and sustained high cortisol all contribute through different routes. The one that surprises people is insulin: high insulin lowers SHBG, the protein that binds testosterone, which raises the free fraction available to be converted.
Can I have hormonal hair loss with normal testosterone?
Yes, and it is the usual situation rather than the exception. Most women with female pattern hair loss have androgen levels inside the reference range. The sensitivity sits at the follicle, in receptor density and in 5-alpha-reductase activity, and no blood test measures either. This is why a normal hormone panel does not rule out androgen-driven thinning. Testing is better understood as a search for the treatable causes sitting alongside it, rather than a way to confirm the diagnosis.
Why did my hair start falling out months after a stressful event?
That delay is the defining feature of telogen effluvium. Illness, surgery, childbirth, a crash diet, or a severe stressor pushes a large share of follicles out of the growth phase at once. They all enter the resting phase together. Resting hairs stay in place for roughly two to three months before they are shed. By the time the shedding starts, the cause is months behind you, which is why people usually blame the wrong event. It also means the shedding is a sign of recovery having already begun.
Does ferritin need to be above 70 for hair to grow?
That figure circulates widely and no strong evidence supports it. Iron deficiency is genuinely associated with hair shedding, and ferritin is the right marker for iron stores because haemoglobin can look normal while stores are empty. No agreed threshold exists for hair specifically. Dermatologists commonly investigate below 30 ng/mL, and the higher targets quoted online come from small studies with inconsistent findings. Iron supplementation carries real risks when it is not needed, so this is a result to interpret with a clinician rather than against a number from a forum.
What treatments are approved for female pattern hair loss?
Topical minoxidil is the only medicine the FDA has approved for hair loss in women, available as a 2% solution and a 5% foam. Low-level laser devices have FDA clearance, a lower regulatory bar than approval. Clearance means a device was judged substantially equivalent to one already on the market, rather than proven effective in its own trials. Finasteride is not approved for women and is contraindicated in anyone who could become pregnant, because it can affect the development of a male fetus. Spironolactone is used off-label as an androgen receptor blocker. Which of these fits a given person is a prescribing decision, not something a page can settle.
Will hair loss from perimenopause grow back?
The two things happening in perimenopause have different answers. The shedding driven by a falling estrogen level behaves like telogen effluvium and generally settles once hormone levels stabilise. The gradual thinning at the crown is female pattern hair loss, which is progressive and does not reverse on its own. Telling them apart is the reason a dermatologist looks at the scalp rather than only at a blood panel.
Related
- Perimenopause symptoms — what else shifts in the same window
- Perimenopause biomarker panel — which markers are worth measuring and when
- PCOS and insulin resistance — the androgen excess route in full
- Ferritin — reading iron stores properly
- TSH — the thyroid screening test and what the ranges mean
- SHBG — the protein that decides how much testosterone is free